Page 9 - Recursion Operating System News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Recursion Announces Multi-Year Collaboration with Mila for Tech-Enabled Drug Discovery

Recursion Announces Multi-Year Collaboration with Mila for Tech-Enabled Drug Discovery
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesSalt lake cityChris gibsonElyse freemanBen mabeyYoshua bengioQuebec artificial intelligence instituteSenior communicationsRecursion coRecursion co founderRecursion chief technology officer benSalt lakeRecursion operating systemRecursion mapProfessor yoshua bengioஒன்றுபட்டது மாநிலங்களில்

Recursion Announces its First Major Multidisciplinary Expansion, in Toronto, to Further Tech-Enabled Drug Discovery

Recursion Announces its First Major Multidisciplinary Expansion, in Toronto, to Further Tech-Enabled Drug Discovery
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Salt lake cityUnited statesChris gibsonElyse freemanJohn toryHeather kirkbyExchange commissionSenior communicationsChief people officer heatherToronto globalToronto regionCanadian trade commissioner serviceToronto mayor johnRecursion operating systemRecursion mapSecurities litigation reform act

Altitude Lab Launches Investor Coalition to Fund and Mentor Healthcare Startups in Utah

Zavain Dar, Lux Capital Altitude Lab, a healthcare and life sciences incubator founded in 2020 by Recursion and The University of Utah s PIVOT Center, fills the critical role of attracting and supporting underrepresented entrepreneurs. The incubator focuses on developing diverse and inclusive businesses to innovate lower cost, higher quality, and more accessible healthcare solutions. Altitude Lab s first cohort includes nine minority or women founders, who are tackling everything from personalized chemotherapy strategies and cancer therapeutics to developing novel platforms to diagnose and triage liver disease. Lack of access to top-tier investors is a crippling gap for founders in nontraditional geographies or of underrepresented backgrounds, explained Chandana Haque, executive director of Altitude Lab. Support from experienced investors can completely change the trajectory of a startup. It s our mission to connect founders from all backgrounds to the capital and resources that

United statesUniversity of utahKatelin robertsZachary bogueJack borenNickolas markNathaniel horwitzAlaa halawaGreg yapChandana haqueJenna barbariAustin waltersZavain darMichael schmanskeNan liKeith marmer

Recursion Announces First Internally-Developed NCE Advanced to IND-Enabling Studies to Potentially Treat Clostridium difficile Colitis

Share this article Share this article SALT LAKE CITY, May 25, 2021 /PRNewswire/ Recursion Pharmaceuticals, Inc. (Nasdaq : RXRX), a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, machine learning (ML), and engineering, today announced the company has initiated investigational new drug (IND)-enabling studies for REC-163964, a first-in-class, small molecule toxin inhibitor for possible prevention of recurrent Clostridium difficile (C. difficile) infections and potential prophylactic use in high-risk patients. REC-163964 is the first internally-discovered New Chemical Entity (NCE) development candidate identified by the Recursion Operating System and advanced to IND-enabling studies. This lead represents one of three structurally-differentiated candidates discovered by Recursion s ML-enabled Operating System for the potential treatment of C. difficile.

Chris gibsonElyse freemanExchange commissionRecursion pharmaceuticals incRecursion pharmaceuticalsNew chemical entityRecursion operating systemOperating systemRecursion mapSecurities litigation reform actகிறிஸ் கிப்சன்பரிமாற்றம் தரகுபுதியது இரசாயன நிறுவனம்இயங்குகிறது அமைப்புபத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம்

Recursion Reports First Quarter 2021 Financials and Provides Business Updates

/PRNewswire/ Recursion Pharmaceuticals, Inc. (Nasdaq : RXRX), a clinical-stage biotechnology company decoding biology by integrating technological.

Salt lake cityUnited statesRamona doyleElyse freemanR martin chavezLouisa danielsRecursion pharmaceuticals incCompany managementPrnewswire recursion pharmaceuticals incDevelopment expensesExchange commissionRecursion coRecursion pharmaceuticalsRecursion co founderSenior vice presidentTranslational medicine